Search Results - seulki+lee

3 Results

Sort By:

Dipicolylamine-based Nanoparticles for Delivery of Ligands

Many potential nucleic acid therapeutics have not transitioned from the research laboratory to clinical application in large part because delivery technologies for these therapies are not effective. Most nucleic acid delivery technologies are lipid-based or positively charged and require chemical or physical conjugation with the nucleic acid. These...

Published: 10/28/2024 | Inventor(s): Seulki Lee, Ki Young Choi, Xiaoyuan (Shawn) Chen

Keywords(s): Acid, DELIVERING, Derivatives, Dipicolylamine, GDXXXX, GXXXXX, Nucleic, THEREOF

Category(s): Collaboration Sought > Collaboration, Application > Therapeutics

Fast Acting Molecular Probes for Real-Time In Vivo Study of Disease and Therapeutics

This technology is for fast acting molecular probes made from a fluorescent quencher molecule, a fluorophore, an enzyme cleavable oligopeptide (for example targeted by protease) and FDA-approved polyethylene glycol (PEG) as well as associated methods to identify cell activity with these probes. Proteases regulate many cell processes such as inflammation...

Published: 10/28/2024 | Inventor(s): Seulki Lee, Lei Zhu, Xiaoyuan (Shawn) Chen

Keywords(s): AA3AXX, AA3XXX, AAXXXX, ACTING, Activity, AXXXXX, Beacon, fast, IMAGING, Molecular, PROTEASE, THEREOF, USES

Category(s): Collaboration Sought > Collaboration

Modified Green Tea Polyphenol EGCG and EGCG-ester Inhibit Endospores

Modified Green Tea Polyphenol EGCG and EGCG-ester Inhibit EndosporesResearchers at Augusta University have invented skin-friendly compositions and methods for killing, inactivating, or otherwise reducing the bacterial endospores by using an effective amount of the green tea EGCG or its derivatives. EGCG research shows clear application for a hand sanitizer...

Published: 4/21/2023 | Inventor(s): Stephen Hsu, Lee Lee, Tin-Chun Chu

Keywords(s):

Category(s): Therapeutics